Novo plans oral Wegovy in France in November, and J.P. Morgan expects third-quarter sales around DKK 76 billion, about 4% above consensus. US scripts dipped for oral Wegovy and Foundayo.
Recap by typeshit. Post by Investseekers on X.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Novo is putting oral treatments and more personalized options first as the market moves past raw weight loss numbers, the CEO told Chosun Ilbo.
He lists what Japanese clinics advertise BPC-157, TB-500 and Epitalon for, and notes the FDA has flagged missing human safety data for several of them.
Loading…